TuHURA Biosciences

(NASDAQ) HURA

Current Price$2.14

Market Cap$136.06M

Since IPO (2024)-63%

5 Year-100%

1 Year-45%

1 Month+52%

TuHURA Biosciences Financials at a Glance

Market Cap

$136.06M

Revenue (TTM)

$0.00

Net Income (TTM)

$30.06M

EPS (TTM)

$-0.63

P/E Ratio

-3.39

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$2.14

Volume

Open

$2.36

Price

$2.14

Volume

Open

$2.36

Previous Close

$2.14

Daily Range

$2.12 - $2.36

52-Week Range

$0.41 - $4.20

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$2.14

Volume

Open

$2.36

Previous Close

$2.14

Daily Range

$2.12 - $2.36

52-Week Range

$0.41 - $4.20

HURA News

TuHURA R&D Jumps 75% in Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TuHURA Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

James A. Bianco, MD

Website

www.tuhurabio.com

Headquarters

Tampa, US

HURA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-169%

Return on Capital

-1%

Return on Assets

-1%

Earnings Yield

-29.50%

Dividend Yield

0.00%

Payout Ratio

-0.03%

Stock Overview

Market Cap

$136.06M

Shares Outstanding

63.58M

Volume

Avg. Volume

1.67M

Financials (TTM)

Gross Profit

$0.00

Operating Income

$31.80M

EBITDA

$29.36M

Operating Cash Flow

$27.63M

Capital Expenditure

$76.08K

Free Cash Flow

$27.71M

Cash & ST Invst.

$3.62M

Total Debt

$502.67K

TuHURA Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$136.06M

N/A

Market Cap/Employee

$7.16M

N/A

Employees

N/A

Net Income

$6.77M

-12.9%

EBITDA

$6.13M

-12.4%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$3.12M

-75.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$303.63K

+611.1%

Short Term Debt

$199.04K

+24.5%

Return on Assets

-1.10%

N/A

Return on Invested Capital

-1.48%

N/A

Free Cash Flow

$5.58M

-113.0%

Operating Cash Flow

$5.56M

-113.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SPROSpero Therapeutics, Inc.

SPROSpero Therapeutics, Inc.$2.50+0.81%

ABOSAcumen Pharmaceuticals, Inc.

ABOSAcumen Pharmaceuticals, Inc.$2.48+4.20%

AGENAgenus Inc.

AGENAgenus Inc.$4.02+4.69%

SEERSeer, Inc.

SEERSeer, Inc.$1.95-3.94%

CGTXCognition Therapeutics, Inc.

CGTXCognition Therapeutics, Inc.$1.28+0.00%

MCRBSeres Therapeutics, Inc.

MCRBSeres Therapeutics, Inc.$7.69+1.05%

INOInovio Pharmaceuticals, Inc.

INOInovio Pharmaceuticals, Inc.$1.14+3.64%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.91-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.51+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.40+0.02%

NOKNokia

NOKNokia$13.14-0.01%

XNDUXanadu Quantum Technologies

XNDUXanadu Quantum Technologies$13.99-0.61%

IRENIren

IRENIren$49.48+0.08%

Questions About HURA

What is the current price of TuHURA Biosciences?

TuHURA Biosciences is trading at $2.14 per share.

What is the 52-week range for TuHURA Biosciences?

Over the past 52 weeks, TuHURA Biosciences has traded between $0.41 and $4.20.

How much debt does TuHURA Biosciences have?

As of the most recent reporting period, TuHURA Biosciences reported total debt of $700,022.

How much cash does TuHURA Biosciences have on hand?

TuHURA Biosciences reported $3.62M in cash and cash equivalents in its most recent financial results.

What is TuHURA Biosciences’s dividend yield?

TuHURA Biosciences does not currently have a dividend yield.

TuHURA Biosciences

TuHURA Biosciences Financials at a Glance

HURA News

TuHURA R&D Jumps 75% in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About TuHURA Biosciences

HURA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

TuHURA Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HURA

What is the current price of TuHURA Biosciences?

What is the 52-week range for TuHURA Biosciences?

How much debt does TuHURA Biosciences have?

How much cash does TuHURA Biosciences have on hand?

What is TuHURA Biosciences’s dividend yield?

Premium Investing Services